v3.25.0.1
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Revenue:    
Revenue $ 65,000
Total revenue 65,000
Cost of goods sold:    
Cost of goods sold 5,200
Total cost of goods sold 5,200
Gross profit 59,800
Operating expenses:    
Research and development 2,223,265 1,432,614
General and administrative 5,013,118 3,994,710
Total operating expenses 7,236,383 5,427,324
Loss from operations (7,236,383) (5,367,524)
Other income (expense), net    
Interest expense (18,158) (79,089)
Loss on conversion of notes (92,959)
Interest income 260,894 183,703
Total other income (expense), net 242,736 11,655
Net loss (6,993,647) (5,355,869)
Deemed dividend related to warrant exercise price adjustment (44,985)
Net loss attributable to common stockholders $ (7,038,632) $ (5,355,869)
Net loss per common share attributable to common stockholders - basic $ (0.85) $ (0.89)
Net loss per common share attributable to common stockholders - diluted $ (0.85) $ (0.89)
Weighted average number of shares outstanding - basic 8,245,353 6,049,819
Weighted average number of shares outstanding - diluted 8,245,353 6,049,819

Source

HTML PDF
ZIP